Others

Curcumin has been shown to have other activities that suggest potential clinical applications, as follows:

• Curcumin was found to be a potent and selective inhibitor of HIV-1 long terminal repeat-directed gene expression, which governs the transcription of HIV-1 provirus.

• Curcumin has been shown to prevent cataractogenesis in an in vitro rat model.

• Treatment with curcumin prevented experimental alcoholic liver disease.

• Curcumin has a protective effect on cyclophosphamide-induced early lung injury.

• Chemotherapy-induced nephrotoxicity can be prevented with curcumin [13].

7.6 Structure Activity Relationship of Curcumin

To elucidate which portion of the molecule is critical for the activity, a large number of structural analogs of curcumin have been synthesized. Some analogues are more active than native curcumin, while others are less active [82]. It was found that the phenolic analogues were more active than the nonphenolic analogues [83]. The highest antioxidant activity was obtained when the phenolic group was steri-cally hindered by the introduction of two methyl groups at the ortho position. The phenolic group is essential for the free-radical scavenging activity, and the presence of the methoxy group further increases the activity [84]. Curcumin shows both antioxidant and pro-oxidant effects. Ahsan et al. have shown that both these effects are determined by the same structural moieties of the curcuminoids [85]. Dinkova-Kostova showed that the presence of hydroxyl groups at the ortho position on the aromatic rings and that beta-diketone functionality was required for high potency in inducing Phase 2 detoxification enzymes [86]. Curcumin is a noncompetitive inhibitor of rat liver microsomal delta 5 desaturase and delta 6 desaturase. Kawashima et al. [87] have shown that only half the structure is essential for the desaturase inhibition. A 3-hydroxy group of the aromatic ring is essential for the inhibition and a free carboxyl group at the end opposite to the aromatic ring interferes with the inhibitory effect. Simon et al. found that the presence of the diketone moiety in the curcumin molecule seems to be essential for its ability to inhibit the proliferation of MCF-7 human breast tumor cells [49]. The aromatic enone and dienone analogs of curcumin have been demonstrated to have potent antiangiogenic property in an in vitro SVR assay [88].

7.7 Conclusions

The medicinal properties of curcumin have been known for centuries, although the scientific basis of its actions has been investigated only over the last couple of decades. Curcumin has been shown to target numerous molecules inside the cell that are known to modulate several signaling pathways. Curcumin is a potent antiox-idant, anti-inflammatory, and anticancer agent and has therapeutic efficacy in numerous diseases. Despite its proven safety over the ages, its efficacy has been limited by its poor solubility, and poor bioavailability. Several analogs of curcumin have been designed to overcome these limitations. Some of these analogs have yielded promising results in in vitro and animal studies, but whether these more bioavailable forms are equally safe is still unknown. Therefore, it is important to evaluate the curcumin analogs for bioavailability and clinical efficacy.

Acknowledgements This work was supported by the Clayton Foundation for Research and a PO1 grant (CA91844) from the National Institutes of Health on lung cancer chemoprevention to BBA.

References

1. Daube FV (1870) Uber Curcumin, den Farbstoff der Curcumawurzel Ber 3:609

2. Lampe V (1910) Ver Dtsch Chem Ger 43:2163

3. Lampe V Milobedzka J (1913) Ver DtschChem Ges 46:2235

4. Srinivasan KR (1952) Curr Sci 21:311

5. Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y (1993) Chem Pharm Bull (Tokyo) 41:1640

6. Prasad NS (1997) Indian Drugs 34:227

7. Chignell CF, Bilski P, Reszka KJ, Motten AG, Sik RH, Dahl TA (1994) Photochem Photobiol 59:295

8. Sharma OP (1976) Biochem Pharmacol 25:1811

9. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R (1995) Cancer Lett 94:79

10. Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, Sun A, Snyder JP, Liotta DC, Jones DP, Shoji M (2005) Anticancer Drugs 16:263

11. Khopde SM, Priyadarsini KI, Venkatesan N, Rao MNA (1999) Biophys Chem 80:83

12. Motterlini R, Foresti R, Bassi R, Green CJ (2000) Free Radic Biol Med 28:1303

13. Shishodia S, Chaturvedi MM, Aggarwal BB (2007) Curr Prob Cancer 31:243-305.

14. Jagetia GC, Aggarwal BB (2007) J Clin Immunol 27:19

15. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, LevinWJ, S Stuart G, Udove J, Ullrich A, et al. (1989) Science 244:707

16. Korutla L, Cheung JY, Mendelsohn J, Kumar R (1995) Carcinogenesis 16:1741

17. Korutla L, Kumar R (1994) Biochim Biophys Acta 1224:597

18. Hong RL, Spohn WH, Hung MC (1999) Clin Cancer Res 5:1884

19. Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007) Adv Exp Med Biol 595:1

20. Bharti AC, Donato N, BB Aggarwal (2003) J Immunol 171:3863

21. Xu J, Fu Y, Chen A (2003) Am J Physiol Gastrointest Liver Physiol 285:G20

22. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L

(1999) Oncogene 18:6013

23. Chen H, Zhang ZS, Zhang YL, Zhou DY (1999) Anticancer Res 19:3675

24. Chun KS, Keum YS, Han SS, Song YS, Kim SH, Surh YJ (2003) Carcinogenesis 24:1515

25. Plummer SM, Hill KA, Festing MF, Steward WP, Gescher AJ, Sharma RA (2001) Cancer Epidemiol Biomarkers Prev 10:1295

26. Reddy S, Aggarwal BB (1994) FEBS Lett 341:19

27. Liu JY, Lin SJ, Lin JK 919930 Carcinogenesis 14:857

28. Hasmeda M, Polya GM (1996) Phytochemistry 42:599

29. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M, Aggarwal BB (2002) C Oncogene 21:8852

30. Ohene-Abuakwa Y, Noda M, Perenyi M, Kobayashi N, Kashima K, Hattori T, Pignatelli M

(2000) J Pathol 192:433

31. Iademarco MF, Barks JL, Dean DC (1995) J Clin Invest 95:264

32. Kumar A, Dhawan S, Hardegen NJ, Aggarwal BB (1998) Biochem Pharmacol 55:775

33. Gupta B, Ghosh B (1999) Int J Immunopharmacol 21:745

34. Jaiswal AS, Marlow BP, Gupta N, Narayan S (2002) Oncogene 21:8414

35. Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB (2002) Carcinogenesis 23:143

36. Shishodia S, Amin HM, Lai R, Aggarwal BB (2005) Biochem Pharmacol 70:700

37. Bharti AC, Donato N, Singh S, Aggarwal BB (2003) Blood 101:1053

38. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, PN Limtrakul (2002) Biochem Pharmacol 64:573

39. Limtrakul P, Anuchapreeda S, Buddhasukh D (2004) BMC Cancer 4:13

40. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer Res 23:363

41. Kuo ML, Huang TS, Lin JK (1996) Biochim Biophys Acta 1317:95

42. Ranjan D, Johnston TD, Reddy KS, Wu G, Bondada S, Chen C (1999) J Surg Res 87:1

43. Piwocka K, Zablocki K, Wieckowski MR, Skierski J, Feiga I, Szopa J, Drela N, Wojtczak L, Sikora E (1999) Exp Cell Res 249:299

44. Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S (1999) Clin Immunol 93:152

45. Chen A, Davis BH, Bissonnette M, Scaglione-Sewell B, Brasitus TA (1999) J Biol Chem 274:35505

46. Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB (2004) Int J Cancer 111:679

47. Mehta K, Pantazis P, McQueen T, Aggarwal BB (1997) Anticancer Drugs 8:470

48. Ramachandran C, You W (1999) Breast Cancer Res Treat 54:269

49. Simon A, Allais DP, Duroux JL, Basly JP, Durand-Fontanier S, Delage C (1998) Cancer Lett 129:111

50. Fang J, Lu J, Holmgren A (2005) J Biol Chem 280:25284

51. Kang J, Chen J, Shi Y, Jia J, Zhang Y (2005) Biochem Pharmacol 69:1205

52. Prusty BK, Das BC (2005) Int J Cancer 113:951

53. Sen S, Sharma H, Singh N (2005) Biochem Biophys Res Commun 331:1245

54. Koo JY, Kim HJ, Jung KO, Park KY (2004) J Med Food 7:117

55. Holy J (2004) Cell Motil Cytoskeleton 58:253

56. Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, Raj-Vadhan S, Estrov Z, Talpaz M, Aggarwal BB (2004) Blood 103:3175

57. Mahady GB, Pendland SL, Yun G, Lu ZZ (2002) Anticancer Res 22:4179

58. Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, Yao PL, Chou HY, Chien CT, Chen WJ, Lee YT, Yang PC (2004) Mol Pharmacol 65:99

59. Kim JH, Shim JS, Lee SK, Kim KW, Rha SY, Chung HC, Kwon HJ (2002) Jpn J Cancer Res 93:1378

60. Kuttan R, Bhanumathy P, Nirmala K, George MC (1985) Cancer Lett 29:197

61. Busquets S, Carbo N, Almendro V, Quiles MT, Lopez-Soriano FJ, Argiles JM (2001) Cancer Lett 167:33

62. Menon LG, Kuttan R, Kuttan G (1995) Cancer Lett 95:221

63. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE (2001) Prostate 47:293

64. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS (1999) Cancer Res 59:597

65. Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, Williams ML, Steward WP, Gescher AJ (2002) Cancer Epidemiol Biomarkers Prev 11:535-540.

66. Odot J, Albert P, Carlier A, Tarpin M, Devy J, Madoulet C (2004) Int J Cancer 111:381

67. Thangapazham RL, Sharma A, Maheshwari RK (2007) Adv Exp Med Biol 595:343

68. Heng MC, Song MK, Harker J, Heng MK (2000) Br J Dermatol 143:937

69. Tourkina E, Gooz P, Oates JC, Ludwicka-Bradley A, Silver RM, Hoffman S (2004) Am J Respir Cell Mol Biol 31:28

70. Sidhu GS, Singh AK, Thaloor D, Banaudha KK, Patnaik GK, Srimal RC, Maheshwari RK (1998) Wound Repair Regen 6:167

71. Phan TT, Sun L, Bay BH, Chan SY, Lee ST (2003) J Trauma 54:1212

72. Deodhar SD, Sethi R, Srimal RC (1980) Indian J Med Res 71:632

73. Liacini A, Sylvester J, Li WQ, Zafarullah M (2002) Matrix Biol 21:251

74. Natarajan C, Bright JJ (2002) J Immunol 168:6506

75. Verbeek R, van Tol EA, van Noort JM (2005) Biochem Pharmacol 70:220

76. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) J Biol Chem 280:5892

77. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) J Neurosci 21:8370

78. Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK (2003) Br J Pharmacol 139:209

79. Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, Jacobson K (2003) Am J Physiol Gastrointest Liver Physiol 285:G235

80. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ (2004) Science 304:600

81. Berger AL, Randak CO, Ostedgaard LS, Karp PH, Vermeer DW, Welsh MJ (2005) J Biol Chem 280:5221

82. Shishodia S, Sethi G, Aggarwal BB (2005) Ann N Y Acad Sci 1056:206

83. Venkatesan P, Rao MN (2000) J Pharm Pharmacol 52:1123

84. Sreejayan N, Rao MN (1996) Arzneimittelforschung 46:169

85. Ahsan H, Parveen N, Khan NU, Hadi SM (1999) Chem Biol Interact 121:161

86. Dinkova-Kostova AT, Talalay P (1999) Carcinogenesis 20:911

87. Kawashima H, Akimoto K, Jareonkitmongkol S, Shirasaka N, Shimizu S (1996) Biosci Biotechnol Biochem 60:108

88. Robinson TP, Ehlers T, Hubbard IR, Bai X, Arbiser JL, Goldsmith DJ, Bowen JP (2003) Bioorg Med Chem Lett 13:115

Was this article helpful?

0 0
Traditional Chinese Medicine

Traditional Chinese Medicine

Ever wondered what Chinese medicine is all about and whether it works? Thinking about consulting a practitioner but want to know some facts first? Look no further! Here's your chance to purchase an in depth and fully comprehensive eBook on anything and everything to do with this ancient philosophy.

Get My Free Ebook


Post a comment